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34 Use of a Tunable Resistive Pulse Sensing System to Detect Drug Response 
from the Mitochondria at Organelle Level 
Loo Fong Chuen (CUHK) 
(Supervisor: Professor Kong Siu Kai, CUHK) 
Single organelle analysis from cancer cells provides a better understanding of the drug effects 
from the isolated organelles for anti-cancer drug development. Since mitochondria play a key 
role in regulating the life and death of cancer cells, we have developed a nanometer-scale 
sensing technique using the Tunable Resistive Pulse Sensing (TRPS) system to compare the 
drug response from single mitochondrion (diameter around 500 nm) isolated from the liver 
cancer cells with or without multidrug resistance (MDR). 
This TRPS technique is based on the detection of blockade events when mitochondria pass 
through a tunable nano-pore for the change in time duration and current magnitude after drug 
treatment. In this presentation, the use of the TRPS system for the detection of mitochondrial 
response upon drug treatment will be highlighted. We first optimized the experimental 
conditions and verified the system by gold nanoparticles, and then applied the system to detect 
the drug response from single mitochondrion isolated from cancer cells. We found that more 
mitochondrial damages include mitochondrial swelling and change in surface charge were 
observed in the cancer cells with MDR when compared to that without MDR after anti-cancer 
drug candidate polyphyllin D treatment. 
 
35 The enzymatic mechanism mediating the breakdown of glycogen in 
hypoxic tumor cells 
K.L.Mung1 , N.S.Wong1 
1.Department of Biochemistry, The University Of Hong Kong 
 
Glycogen has been recently implicated as a major source of metabolic fuel for hypoxic tumor 
cells. The biochemical mechanism underlying the breakdown of glycogen to produce the 
substrate for glycolysis though is not fully understood. The aim of this study is to demonstrate 
the potential role of glycogen phosphorylase or α-glucosidase in mediating breakdown of 
intracellular glycogen in hypoxic tumor cells. The deprivation of glucose in normoxic tumor 
cells over a period of 6 hours resulted in marked reduction of intracellular glycogen level. 
Imposing hypoxia (1% O2) on these cells during the last three hours of glucose deprivation 
accelerated the decrease of intracellular glycogen content. The co-incubation of cells with a 
specific glycogen phosphorylase inhibitor (GPI) but not a α-glucosidase inhibitor (miglitol) 
prevented the loss of intracellular glycogen seen in glucose-deprived cells under normoxic 
condition. However, GPI or miglitol alone or together had no effect on the enhanced loss of 
glycogen seen in the hypoxic cells. Results of in vitro enzyme assays for glycogen 
phosphorylase activity extracted from hypoxic cells showed that both the AMP-independent 
and the AMP-dependent component of the enzyme activity could be effectively inhibited by 
GPI. Our data suggest that the degradation of intracellular glycogen in hypoxic tumor cells is 
unlikely to be mediated by either glycogen phosphorylase or α-glucosidase. Further 
confirmation of this hypothesis will be achieved by knockdown experiments of glycogen 
phosphorylase expression decreased after hypoxic treatment. 
 
 
 
 
 
 
 
 
 
 
